Paradigm Capital Management Inc Standard Biotools Inc. Transaction History

Paradigm Capital Management Inc

$2.03 Billion
Q2 2025

A detailed history of Paradigm Capital Management Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 17,457 shares of LAB stock, worth $23,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,457

Previous 248,400 92.97%

Holding current value

$23,392

Previous $268,000 92.54%

% of portfolio

0.0%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.92 - $1.27 $212,467 - $293,297	-230,943 Reduced 92.97%	17,457 $20,000
Q1 2025 May 15, 2025	BUY	$1.01 - $2.06 $250,884 - $511,704	248,400 New	248,400 $268,000
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $935,000 - $1.39 Million	500,000 Added 1000.0%	550,000 $1.49 Million
Q4 2023 Feb 13, 2024	BUY	$1.59 - $2.73 $79,500 - $136,500	50,000 New	50,000 $110,000
Q1 2022 May 25, 2022	SELL	$2.8 - $3.96 $2.16 Million - $3.05 Million	-771,100 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$3.63 - $6.13 $525,987 - $888,237	-144,900 Reduced 15.82%	771,100 $3.02 Million
Q3 2021 Nov 08, 2021	SELL	$5.5 - $7.41 $5.04 Million - $6.79 Million	-916,000 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$4.35 - $6.35 $1.43 Million - $2.09 Million	-329,000 Reduced 26.43%	916,000 $5.64 Million
Q1 2021 May 05, 2021	SELL	$3.94 - $7.09 $1.11 Million - $1.99 Million	-281,100 Reduced 18.42%	1,245,000 $5.63 Million
Q4 2020 Jan 20, 2021	BUY	$5.45 - $8.65 $2.95 Million - $4.69 Million	542,000 Added 55.08%	1,526,100 $9.16 Million
Q3 2020 Oct 20, 2020	SELL	$4.34 - $11.43 $2.26 Million - $5.96 Million	-521,600 Reduced 34.64%	984,100 $7.31 Million
Q2 2020 Aug 03, 2020	BUY	$1.85 - $5.29 $33,300 - $95,220	18,000 Added 1.21%	1,505,700 $6.04 Million
Q1 2020 May 12, 2020	BUY	$1.24 - $4.35 $1 Million - $3.52 Million	809,800 Added 119.46%	1,487,700 $3.78 Million
Q4 2019 Feb 05, 2020	BUY	$2.3 - $5.12 $1.27 Million - $2.83 Million	552,700 Added 441.45%	677,900 $2.36 Million
Q3 2019 Nov 07, 2019	BUY	$4.63 - $12.15 $579,676 - $1.52 Million	125,200 New	125,200 $580,000

Others Institutions Holding LAB

# of Institutions

166

Shares Held

278M

Call Options Held

34.9K

Put Options Held

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $105M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.

Account

Paradigm Capital Management Inc Standard Biotools Inc. Transaction History